[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Viral vector manufacturing Market  

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          By Type

4.1       Introduction

4.1.1    Market Size & Forecast (Value)

  4.2       Retrovirus Vectors

  4.3       Adenovirus Vectors

  4.4       Adeno-Associated Viral Vectors

  4.5       others

5.         By Disease

            5.1       Introduction

                        5.1.1    Market Size & Forecast (Value)

            5.2       Cancer

            5.3       Genetic Disorders

6      By Application

            6.1       Introduction

                        6.1.1    Market Size & Forecast (Value)

            6.2       Gene Disease

            6.3       Vaccinology

7.         By End User

            7.1       Introduction

                        7.1.1    Market Size & Forecast (Value)

             7.2      Pharmaceutical and Biopharmaceutical Companies

            7.3       Research Centers

            7.4       Others

8.         By Regional Overview          

8.1       Introduction 

                        8.1.1    Market Size & Forecast (Value)         

            8.2       America         

                        8.2.1    North America           

                        8.2.2    U.S.     

                                    8.2.2.1     By Disease      

                                     8.2.2.2     By Type         

                        8.2.3    Canada           

                                    8.2.3.1     By Disease      

                                    8.2.3.2     By Type          

                        8.2.4    Mexico           

                                    8.2.4.1     By Disease      

                                    8.2.4.2     By Type          

                        8.2.5    Latin America

                                    8.2.5.1     By Disease

                                    8.2.5.2      By Type

            8.3       Europe           

                        8.3.1    Market Size & Forecast (Value)         

                        8.3.2    Germany        

                                    8.3.2.1     By Disease      

                                    8.3.2.2     By Type          

                        8.3.3    France

                                    8.3.3.1     By Disease      

                                    8.3.3.2     By Type          

                        8.3.4    U.K      

                                    8.3.4.1     By Disease      

                                    8.3.4.2      By Type          

                        8.3.5    Italy    

                                    8.3.5.1     By Disease      

                                    8.3.5.2     By Type          

                        8.3.6    Spain  

                                    8.3.6.1     By Disease      

                                    8.3.6.2     By Type

                        8.3.7    Rest of Europe

                                    8.3.7.1     By Disease

                                    8.3.7.2     By Type

             8.4      Asia Pacific    

                                    8.4.1    Market Size & Forecast (Value)         

                                    8.4.2    Japan  

                                                8.4.2.1     By Disease

                                                8.4.2.2     By Type      

                                    8.4.3    China  

                                                8.4.3.1     By Disease

                                                8.4.3.2     By Type

                                    8.4.4    Australia         

                                                8.4.4.1     By Disease  

                                                8.4.4.2     By Type      

                                    8.4.5    India   

                                                8.4.5.1     By Disease  

                                                8.4.5.2     By Type

                                    8.4.6    South Korea    

                                                8.4.6.1     By Disease  

                                                8.4.6.2     By Type      

                                    8.4.7    Rest of Asia-Pacific    

                                                8.4.7.1     By Disease  

                                                8.4.7.2     By Type     

            8.5       Middle East & Africa

                                    8.5.1    Market Size & Forecast (Value)         

                                    8.5.2    Saudi Arabia   

                                                8.5.2.1     By Disease      

                                                8.5.2.2     By Type          

                                    8.5.3    South Africa   

                                                8.5.3.1     By Disease      

                                                8.5.3.2     By Type          

                                    8.5.4    Kuwait

                                                8.5.4.1     By Disease      

                                                8.5.4.2     By Type          

                                    8.5.5    Rest of Middle East & Africa 

                                                8.5.5.1     By Disease      

                                                8.5.5.2     By Type          

9.         Company Profile                  

                        9.1       Merck kGA

                                    9.1.1    Company Overview   

                                    9.1.2    Financial Performance          

                                    9.1.3    Recent Developments

                                    9.1.4    Disease Portfolio        

                        9.2       Lonza

                                    9.2.1    Company Overview   

                                    9.2.2    Financial Performance          

                                    9.2.3    Recent Developments

                                    9.2.4    Disease Portfolio        

                        9.3       BD

                                    9.3.1    Company Overview   

                                    9.3.2    Financial Performance          

                                    9.3.3    Recent Developments

                                    9.3.4    Disease Portfolio

 

                        9.4       Fujifilm Diosynth biotechnologies USA Inc

                                    9.4.1    Company Overview   

                                    9.4.2    Financial Performance          

                                    9.4.3    Recent Developments

                                    9.4.4    Disease Portfolio        

                        9.5       Brammer Bio

                                    9.5.1    Company Overview   

                                    9.5.2    Financial Performance          

                                    9.5.3    Recent Developments

                                    9.5.4    Disease Portfolio        

                        9.6       Cell Therapy Catapult Limited

                                    9.6.1    Company Overview   

                                    9.6.2    Financial Performance          

                                    9.6.3    Recent Developments

                                    9.6.4    Disease Portfolio        

                        9.7       Waisman Biomanufacturing

                                    9.7.1    Company Overview   

                                    9.7.2    Financial Performance          

                                    9.7.3    Recent Developments

                                    9.7.4    Disease Portfolio

                        9.8       GENEZEN LABORATORIES

                                    9.8.1    Company Overview   

                                    9.8.2    Financial Performance          

                                    9.8.3    Recent Developments

                                    9.8.4    Disease Portfolio

                        9.9       Yposkesi, Inc

                                    9.9.1    Company Overview   

                                    9.9.2    Financial Performance          

                                    9.9.3    Recent Developments

                                    9.9.4    Disease Portfolio        

                        10.1     REGENXBIO Inc

                                    10.10.1 Company Overview  

                                    10.10.2 Financial Performance         

                                    10.10.3 Recent Development

   10.10.4 Disease Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports